| Danville Oral And Maxillofacial Surgery | |
|
400 S 4th St Danville KY 40422-2007 | |
| (859) 236-1130 | |
| (859) 239-9384 |
| Full Name | Danville Oral And Maxillofacial Surgery |
|---|---|
| Speciality | Dentist |
| Location | 400 S 4th St, Danville, Kentucky |
| Authorized Official Name and Position | Sherry L Peavler (OFFICE MANAGER) |
| Authorized Official Contact | 8592361130 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Danville Oral And Maxillofacial Surgery 400 S 4th St Ste 201 Danville KY 40422-2094 Ph: (859) 236-1130 | Danville Oral And Maxillofacial Surgery 400 S 4th St Danville KY 40422-2007 Ph: (859) 236-1130 |
| NPI Number | 1730259292 |
|---|---|
| Provider Enumeration Date | 11/09/2006 |
| Last Update Date | 02/23/2017 |
| Medicare PECOS PAC ID | 5799757514 |
|---|---|
| Medicare Enrollment ID | O20040811000602 |
News Archive
A new study in the American Journal of Preventive Medicine, published by Elsevier, demonstrated that employees at a large urban hospital who purchased the least healthy food in its cafeteria were more likely to have an unhealthy diet outside of work, be overweight and/or obese, and have risk factors for diabetes and cardiovascular disease, compared to employees who made healthier purchases.
Researchers at Ohio State University Medical Center and Nationwide Children's Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Despite continued improvements in antibiotics and hospital intensive care, staph sepsis -; a bloodstream infection caused by Staphylococcus aureus bacteria -; still causes severe illness or death in 20 to 30 percent of patients who contract it.
As DNA testing expands and the price and speed of sequencing equipment improves, it's not out of the question that the half-million dollar sequencers now only available in top research labs may find their way into routine hospital and physician office labs throughout the U.S. over the next decade, according to the findings of Kalorama Information.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730259292 | NPI | - | NPPES |
| 64031842 | Medicaid | KY | |
| 61941860 | Medicaid | KY | |
| 65912990 | Medicaid | KY | |
| 60003175 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | (Kentucky) | Primary |
| 174400000X | Specialist | (* (Not Available)) | Secondary |
| Provider Name | Louis Beto |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1114981420 PECOS PAC ID: 5597737312 Enrollment ID: I20120524000531 |
News Archive
A new study in the American Journal of Preventive Medicine, published by Elsevier, demonstrated that employees at a large urban hospital who purchased the least healthy food in its cafeteria were more likely to have an unhealthy diet outside of work, be overweight and/or obese, and have risk factors for diabetes and cardiovascular disease, compared to employees who made healthier purchases.
Researchers at Ohio State University Medical Center and Nationwide Children's Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Despite continued improvements in antibiotics and hospital intensive care, staph sepsis -; a bloodstream infection caused by Staphylococcus aureus bacteria -; still causes severe illness or death in 20 to 30 percent of patients who contract it.
As DNA testing expands and the price and speed of sequencing equipment improves, it's not out of the question that the half-million dollar sequencers now only available in top research labs may find their way into routine hospital and physician office labs throughout the U.S. over the next decade, according to the findings of Kalorama Information.
› Verified 8 days ago
| Provider Name | Amy Jane Bogardus |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1558325878 PECOS PAC ID: 5991972127 Enrollment ID: I20120524000553 |
News Archive
A new study in the American Journal of Preventive Medicine, published by Elsevier, demonstrated that employees at a large urban hospital who purchased the least healthy food in its cafeteria were more likely to have an unhealthy diet outside of work, be overweight and/or obese, and have risk factors for diabetes and cardiovascular disease, compared to employees who made healthier purchases.
Researchers at Ohio State University Medical Center and Nationwide Children's Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Despite continued improvements in antibiotics and hospital intensive care, staph sepsis -; a bloodstream infection caused by Staphylococcus aureus bacteria -; still causes severe illness or death in 20 to 30 percent of patients who contract it.
As DNA testing expands and the price and speed of sequencing equipment improves, it's not out of the question that the half-million dollar sequencers now only available in top research labs may find their way into routine hospital and physician office labs throughout the U.S. over the next decade, according to the findings of Kalorama Information.
› Verified 8 days ago
| Provider Name | Justin R Kolasa |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1598100372 PECOS PAC ID: 1557697794 Enrollment ID: I20190725003816 |
News Archive
A new study in the American Journal of Preventive Medicine, published by Elsevier, demonstrated that employees at a large urban hospital who purchased the least healthy food in its cafeteria were more likely to have an unhealthy diet outside of work, be overweight and/or obese, and have risk factors for diabetes and cardiovascular disease, compared to employees who made healthier purchases.
Researchers at Ohio State University Medical Center and Nationwide Children's Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Despite continued improvements in antibiotics and hospital intensive care, staph sepsis -; a bloodstream infection caused by Staphylococcus aureus bacteria -; still causes severe illness or death in 20 to 30 percent of patients who contract it.
As DNA testing expands and the price and speed of sequencing equipment improves, it's not out of the question that the half-million dollar sequencers now only available in top research labs may find their way into routine hospital and physician office labs throughout the U.S. over the next decade, according to the findings of Kalorama Information.
› Verified 8 days ago
News Archive
A new study in the American Journal of Preventive Medicine, published by Elsevier, demonstrated that employees at a large urban hospital who purchased the least healthy food in its cafeteria were more likely to have an unhealthy diet outside of work, be overweight and/or obese, and have risk factors for diabetes and cardiovascular disease, compared to employees who made healthier purchases.
Researchers at Ohio State University Medical Center and Nationwide Children's Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.
Despite continued improvements in antibiotics and hospital intensive care, staph sepsis -; a bloodstream infection caused by Staphylococcus aureus bacteria -; still causes severe illness or death in 20 to 30 percent of patients who contract it.
As DNA testing expands and the price and speed of sequencing equipment improves, it's not out of the question that the half-million dollar sequencers now only available in top research labs may find their way into routine hospital and physician office labs throughout the U.S. over the next decade, according to the findings of Kalorama Information.
› Verified 8 days ago
Danville Peds Dre Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1080 Ben Ali Dr Ste A, Danville, KY 40422 Phone: 859-236-6900 | |
Robert Taylor Dmd, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 435 Whirlaway Dr, Danville, KY 40422 Phone: 859-236-4304 | |
Bostick Dental Center Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 122 Daniel Dr, Danville, KY 40422 Phone: 859-236-1810 Fax: 859-236-1802 | |
Susan H. Couzens Dmd Psc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 S 4th St, Suite 101, Danville, KY 40422 Phone: 859-236-4304 | |
Webster Orthodontics Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 359 S 4th St Ste B, Danville, KY 40422 Phone: 859-236-1912 Fax: 859-236-4589 | |
Boyd Family Dentistry Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 151 N 3rd St, Suite 2, Danville, KY 40422 Phone: 859-236-8229 | |
Chris Bostick, Dmd,pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 129 Daniel Dr, Danville, KY 40422 Phone: 859-236-1810 Fax: 859-236-1802 |